Skip to main content

Animations

MJFF Publications

7111 - 7120 of 8808 Results
Title
Year
  • Year
  • 2020
  • 2024
  • 2024
  • 2018
  • 2024
  • 2021
  • 2023
  • 2018
  • 2015
  • 2021
  • Summary Details
    OPEN
    Title: A novel homozygous KY variant causing a complex neurological disorder
    Journal Name: European Journal of Medical Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejmg.2020.104031
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Multiscale Modeling of Magnetoelectric Nanoparticles for the Analysis of Spatially Selective Neural Stimulation
    Journal Name: Advanced Healthcare Materials
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/adhm.202302871
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Effect of the mGlu 2 positive allosteric modulator biphenyl‐indanone A as a monotherapy and as adjunct to a low dose of L‐DOPA in the MPTP‐lesioned marmoset
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16454
    Citation Count: 3
  • Summary Details
    OPEN
    Title: L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles
    Journal Name: Nanomedicine: Nanotechnology, Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nano.2018.08.011
    Citation Count: 88
  • Summary Details
    OPEN
    Title: Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-024-12554-3
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Advances in protein-protein interaction network analysis for Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2021.105395
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Simultaneous Determination of the Size and Shape of Single α-Synuclein Oligomers in Solution
    Journal Name: ACS Nano
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acsnano.3c01393
    Citation Count: 29
  • Summary Details
    OPEN
    Title: TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease
    Journal Name: Journal of Experimental Medicine
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1084/jem.20180484
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer’s disease patients
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2015.02.013
    Citation Count: 11
  • Summary Details
    RESTRICTED
    Title: Mindfulness based stress reduction in people with Parkinson's disease and their care partners
    Journal Name: Complementary Therapies in Clinical Practice
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ctcp.2021.101377
    Citation Count: 12
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.